They offer better uptake, especially for skin health or detoxification
Fortunately, there may be more insight in the near future - the FOCUS trial, with anticipated completion in November 2027, is currently underway to evaluate the long-term effects of semaglutide on DR
Its an area of active research, with studies being done to support these initial benefits and reveal new ones.
Mallya is a smart sensor that has been designed to be attached directly to insulin pen injectors, converting them into connected devices
A few states (like California, Texas, and Florida) have stricter enforcement of clinical-justification requirements for compounded GLP-1
They are not substitutes for the underlying physiology